BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sabnis RW. Novel Substituted Tetrazoles as ACSS2 Inhibitors for Treating Cancer. ACS Med Chem Lett 2021;12:1894-5. [PMID: 34917250 DOI: 10.1021/acsmedchemlett.1c00621] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Hao Y, Yi Q, Xiaowu X, Weibo C, Guangchen Z, Xuemin C. Acetyl-CoA: An interplay between metabolism and epigenetics in cancer. Front Mol Med 2022;2. [DOI: 10.3389/fmmed.2022.1044585] [Reference Citation Analysis]
2 Cui M, Yi X, Cao Z, Zhu D, Wu J, Raghavamenon AC. Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and the Immune Microenvironment in Esophageal Cancer: A Review. Journal of Oncology 2022;2022:1-27. [DOI: 10.1155/2022/4257359] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Kou Y, Geng F, Guo D. Lipid Metabolism in Glioblastoma: From De Novo Synthesis to Storage. Biomedicines 2022;10:1943. [DOI: 10.3390/biomedicines10081943] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ling R, Chen G, Tang X, Liu N, Zhou Y, Chen D. Acetyl-CoA synthetase 2(ACSS2): a review with a focus on metabolism and tumor development. Discov Oncol 2022;13:58. [PMID: 35798917 DOI: 10.1007/s12672-022-00521-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Liu M, Liu N, Wang J, Fu S, Wang X, Chen D. Acetyl-CoA Synthetase 2 as a Therapeutic Target in Tumor Metabolism. Cancers (Basel) 2022;14:2896. [PMID: 35740562 DOI: 10.3390/cancers14122896] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]